Utilization Patterns Explain Nonadherence to Treatment for Multiple Myeloma, CML, Some Metastatic Cancers
A retrospective study of Medicare data showed a potential factor in nonadherence to oral cancer treatment regimens.
Multiple Myeloma
Vertebroplasty, Balloon Kyphoplasty Are Viable Options for PVF in Multiple Myeloma
A review of data in the literature sought to determine whether these procedures have a role in managing vertebral metastasis and subsequent pathological vertebral fractures in patients with MM.
Prognostic Importance of Extramedullary Lesions in Multiple Myeloma
Researchers sought to determine whether extramedullary lesions would be an indicator of prognosis in patients with multiple myeloma treated in the first line with bortezomib.
A Case of Multiple Myeloma Presenting With Ophthalmic Changes
A case report describes an atypical presentation of multiple myeloma marked by immunogammopathy maculopathy and hyperviscosity syndrome-related retinopathy.
Venetoclax Combinations Found Effective in Relapsed/Refractory MM, With or Without t(11;14)
Researchers sought to determine which of 2 combination regimens would be a more effective treatment for patients with relapsed/refractory multiple myeloma.
Daratumumab-Based Regimens Associated With Sustained MRD Negativity in Multiple Myeloma
Patients who received daratumumab were more likely to be MRD negative at 12 months and beyond.
CHIP May Affect Some Outcomes in Patients Receiving CAR T-Cell Therapy
CHIP was associated with higher rates of complete response and cytokine release syndrome.
Dosing Schedule of Intravenous Bisphosphonate Has Little Effect on Recurrent Skeletal-Related Events in Patients With Multiple Myeloma
No significant difference in SRE risk on the basis of intravenous bisphosphonate dosing was observed for patients with newly diagnosed multiple myeloma.
ASCT-Related Symptoms Influence Quality of Life for Patients With Lymphoma, Myeloma
Study sought to determine the effect of symptoms on HRQOL in patients with myeloma or lymphoma undergoing autologous stem cell transplantation.
Can Patients With Multiple Myeloma Boost Their Immunity?
Multiple myeloma (MM) is not a disease with a known cure, but recent studies have suggested that focusing on boosting immunity in patients with MM may help their chances at longer-term survival. What are these immunity-focused treatment options?
- Loading...
Loading...
Next post in Multiple Myeloma
Loading... 
Loading...